EUVIMEDEUVIMED entdecken
Multizentrische Studie

Topiramate ban in women of childbearing potential with idiopathic generalized epilepsy: Does effectiveness offset the teratogenic risks?

Emanuele Cerulli Irelli iD, Enrico Cocchi, Barbara Mostacci, Biagio Orlando, Joanna Gesche, Roberto H Caraballo iD, Simona Lattanzi iD, Gionata Strigaro, Cecilia Catania, Patrizia Pulitano, Chiara Panzini, Edoardo Ferlazzo und 15 weitere

Epilepsia · 2024

DOI: 10.1111/epi.17892 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Epilepsia, 2024. Verfasst von Emanuele Cerulli Irelli und 26 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Neurosciences, Sapienza University, Rome, Italy. Hauptthemen laut MEDLINE: Epilepsy, Epilepsy, Generalized. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Regulatory agencies have recently discouraged the prescription of topiramate (TPM) to women of childbearing potential with epilepsy due to growing evidence of the teratogenic and neurodevelopmental risks associated with its use during pregnancy. It remains, however, unclear whether the use of TPM in this population can be supported to some extent by its high effectiveness. In this multicenter, retrospective, cohort study performed at 22 epilepsy centers, we investigated the comparative effectiveness of TPM and levetiracetam (LEV) given as first‐line antiseizure medication in a cohort of women of childbearing potential with idiopathic generalized epilepsy (IGE). A total of 336 participants were included, of whom 24 (7.1%) received TPM and 312 (92.9%) LEV. Women treated with TPM had significantly higher risks of treatment failure and treatment withdrawal and were less likely to achieve seizure freedom at 12 months compared to women treated with LEV. In conclusion, this study highlighted a low tendency among clinicians to use TPM in women of childbearing potential with IGE, anticipating the recently released restrictions on its use. Furthermore, the available data on effectiveness do not appear to support the use of TPM in this population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EpilepsyEpilepsy, GeneralizedPregnancyHumansFemaleTopiramateAnticonvulsantsTeratogensRetrospective StudiesCohort StudiesFructoseLevetiracetamImmunoglobulin E

Stichwörter der Autor:innen

antiseizure medicationlevetiracetammonotherapyreproductive age

Substanzen

TopiramateAnticonvulsantsTeratogensFructoseLevetiracetamImmunoglobulin E

Autor:innen und Institutionen

  • Department of Human Neurosciences, Sapienza University, Rome, Italy.
  • Department of Precision Medicine and Genomics, Department of Medicine, Columbia University, New York, New York, USA.
  • IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.
  • Department of Neurology, Odense University Hospital, Odense, Denmark.
  • Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
  • Department of Neurology, Hospital de Pediatría "Prof. Dr. Juan P. Garrahan", Buenos Aires, Argentina.

ORCID-Profile: Emanuele Cerulli Irelli, Roberto H Caraballo, Simona Lattanzi, Angelo Pascarella, Chiara Pizzanelli, Loretta Giuliano, Francesco Fortunato, Antonio Gambardella, Angelo Labate, Francesca F Operto, Christoph P Beier, Carlo Di Bonaventura

Zitieren

APA

Cerulli Irelli, E., Cocchi, E., Mostacci, B., Orlando, B., Gesche, J., Caraballo, R. H., Lattanzi, S., Strigaro, G., Catania, C., Pulitano, P., Panzini, C., Ferlazzo, E., Pascarella, A., Casciato, S., Pizzanelli, C., Giuliano, L., Viola, V., Fortunato, F., Di Gennaro, G., …, & Women With Epilepsy Treatment Options and Research Study Group (2024). Topiramate ban in women of childbearing potential with idiopathic generalized epilepsy: Does effectiveness offset the teratogenic risks?. Epilepsia. https://doi.org/10.1111/epi.17892

Vancouver

Cerulli Irelli E, Cocchi E, Mostacci B, Orlando B, Gesche J, Caraballo RH, et al. Topiramate ban in women of childbearing potential with idiopathic generalized epilepsy: Does effectiveness offset the teratogenic risks?. Epilepsia. 2024. doi:10.1111/epi.17892

BibTeX
@article{CerulliIrelli2024,
  author = {Cerulli Irelli, Emanuele and Cocchi, Enrico and Mostacci, Barbara and Orlando, Biagio and Gesche, Joanna and Caraballo, Roberto H and Lattanzi, Simona and Strigaro, Gionata and Catania, Cecilia and Pulitano, Patrizia and Panzini, Chiara and Ferlazzo, Edoardo and Pascarella, Angelo and Casciato, Sara and Pizzanelli, Chiara and Giuliano, Loretta and Viola, Veronica and Fortunato, Francesco and Di Gennaro, Giancarlo and Gambardella, Antonio and Labate, Angelo and Operto, Francesca F and Giallonardo, Anna T and Baykan, Betul and Beier, Christoph P and Di Bonaventura, Carlo and Women With Epilepsy Treatment Options and Research Study Group, Women With Epilepsy Treatment Options and Research Study Group},
  title = {Topiramate ban in women of childbearing potential with idiopathic generalized epilepsy: Does effectiveness offset the teratogenic risks?},
  journal = {Epilepsia},
  year = {2024},
  doi = {10.1111/epi.17892}
}
Kostenlos starten →